The Optimization Blueprint — the algorithm Jonathan Murphy, PMHNP-BC, uses to find the right medication and the right dose for adults with ADHD.
This episode is for two audiences simultaneously: clinicians refining their adult ADHD prescribing practice and patients trying to understand whether their current treatment is optimized.
This episode covers:
- The three medication categories: methylphenidate, amphetamine, and non-stimulant
- Why extended-release stimulants are first-line and why the "controlled substance" framing misleads prescribers
- The standard adult starting doses for the major medications
- The response and toleration framework for assessing the first prescription
- When to start with amphetamine versus methylphenidate based on presentation
- Why methylphenidate is often the better starting point despite being less culturally familiar
- What "optimized" actually means: all good, no bad, no side effects, works like a vitamin
- The risk of dysfunctional medication relationships and how they form
- Why providers who haven't developed comfort with adult ADHD prescribing should consider referring out rather than under-treating
This is the second episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T
Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.
For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.